MetLife Investment Advisors »

Esperion Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $282k 107k 2.65
2025-06-30 $121k 123k 0.98
2025-03-31 $108k 75k 1.44
2024-12-31 $259k 118k 2.20
2024-09-30 $117k 71k 1.65
2024-06-30 $107k 48k 2.22
2023-03-31 $22k 14k 1.59
2022-12-31 $216k 35k 6.23
2022-09-30 $232k 35k 6.69
2022-06-30 $189k 30k 6.36
2022-03-31 $163k 35k 4.64
2021-09-30 $71k 5.9k 12.05
2021-06-30 $268k 13k 21.15
2021-03-31 $356k 13k 28.06
2020-12-31 $330k 13k 26.00
2020-09-30 $472k 13k 37.17
2020-06-30 $651k 13k 51.32
2020-03-31 $344k 11k 31.53
2019-12-31 $650k 11k 59.63
2019-09-30 $400k 11k 36.66
2019-06-30 $507k 11k 46.52
2019-03-31 $438k 11k 40.18
2018-12-31 $501k 11k 45.96
2018-09-30 $750k 17k 44.34
2018-06-30 $427k 11k 39.17
2018-03-31 $545k 7.5k 72.30
2017-12-31 $496k 7.5k 65.80